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Abstract
Introduction
To  provide  direction  and  to  support  improvements  in 
diabetes care, states must be able to measure the effective-
ness of interventions and gain feedback on progress. We 
wanted to know if data from multiple health clinics that 
are implementing quality improvement strategies could be 
combined to provide useful measurements of diabetes care 
processes and control of intermediate outcomes.
Methods
We  combined  and  analyzed  electronic  patient  health 
data from clinic sites across Washington State that used 
the  Chronic  Disease  Electronic  Management  System 
(CDEMS)  registry.  The  data  were  used  to  determine 
whether  national  and  state  objectives  for  diabetes  care 
were met. We calculated the percentage of patients that 
met standards of care in 2004.
Results
The pooled dataset included 17,349 adult patients with 
diabetes from 90 clinics. More than half of patients were 
above  recommended  target  levels  for  hemoglobin  A1c 
testing,  foot  examination,  hemoglobin  A1c  control,  and 
low-density lipoprotein cholesterol control. Fewer patients 
met  recommendations  for  nephropathy  assessment,  eye 
examinations,  and  blood  pressure  control.  In  terms  of 
meeting  these  standards,  rates  of  diabetes  care  varied 
across clinics. CDEMS rates of care were compared with 
those reported by other data sources, but no consistent 
pattern of similarities or differences emerged.
Conclusion
With  committed  staff  time,  provider  support,  and 
resources,  data  from  clinical  information  systems  like 
CDEMS  can  be  combined  to  address  a  deficiency  in 
state-level diabetes surveillance and evaluation systems 
— specifically, the inability to capture clinical biometric 
values to measure intermediate health outcomes. These 
data can complement other surveillance and evaluation 
data sources to help provide a better picture of diabetes 
care in a state.
Introduction
Diabetes is a growing public health problem (1), but care 
continues to be less than optimal (2-4), despite evidence 
that  effective  and  economical  interventions  can  result 
in  fewer  complications  and  improved  outcomes  (5-7). 
Therefore, the Institute of Medicine labeled diabetes as a 
priority area for quality improvement in the United States 
(8) and suggested substantial changes in and redesign of 
health care systems (9), including better use of informa-
tion technology to monitor health care. 
National  and  state  objectives  for  diabetes  care  are   
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used  to  evaluate  the  effectiveness  of  prevention  and   
intervention activities (10). Local targets for these objec-
tives have been set by each state’s Diabetes Prevention and 
Control Program (DPCP). Objectives for the Washington 
State  DPCP  focus  on  increasing  population-level  rates 
of process measures (annual foot and eye examinations, 
biannual hemoglobin A1c [HbA1c] tests, annual nephropa-
thy assessment, annual influenza vaccination, and previ-
ous pneumococcal vaccination) and intermediate outcomes 
(controlled  levels  of  HbA1c,  blood  pressure,  and  low- 
density lipoprotein [LDL] cholesterol).
States must be able to measure the cumulative effect of 
broad community, health system, and health communica-
tion interventions and to monitor progress toward diabetes 
objectives over time. Aggregate data from individual clini-
cal information systems have been used by large organiza-
tions, including health care systems, federal health care 
organizations, and community health centers to monitor, 
coordinate, and manage care for targeted diabetes popula-
tions  (11-22).  State  health  departments,  however,  have 
used these kinds of data to only a limited degree (23). The 
lack of state-specific surveillance data for measuring prog-
ress on 3 diabetes indicators — glucose, lipid, and blood 
pressure control — is a deficiency in evidence supporting 
the impact of a state health department’s effort to improve 
diabetes outcomes.
In 2005, the Washington State DPCP assessed its prog-
ress toward meeting state and national diabetes objectives 
to determine whether established targets for each objective 
needed to be modified. An extensive review of population-
based data was done to ascertain what data sources could 
be incorporated into the surveillance program to help track 
progress  toward  meeting  objectives.  Whereas  the  DPCP 
regularly uses statewide BRFSS (Behavioral Risk Factor 
Surveillance System) telephone survey data to monitor pro-
cesses of care (foot examination, eye examination, HbA1c 
testing,  and  influenza  and  pneumococcal  vaccinations), 
no  statewide  source  exists  for  collecting  information  on 
nephropathy screening and intermediate health outcomes 
(glucose, lipid, and blood pressure control). For this reason, 
the  DPCP  decided  to  explore  the  feasibility  of  obtain-
ing  data  from  a  patient  registry  known  as  the  Chronic 
Disease Electronic Management System (CDEMS), which 
is used by primary care providers across Washington (24). 
CDEMS is the only source of state-specific data available 
to the DPCP to monitor nephropathy screening and HbA1c,   
LDL,  and  blood  pressure  values  among  a  large  patient 
population  with  diabetes.  Consolidated  data  from  all 
Washington clinics using CDEMS covered approximately 
13% of all state residents with diabetes in 2004.
Our goals for this data consolidation project were to   
1) measure the status of patients in CDEMS registries in 
terms of meeting state and national objectives for diabe-
tes, 2) provide aggregate comparison data for individual 
clinics using CDEMS, and 3) determine the feasibility 
of combining and using clinic data for ongoing diabetes 
surveillance and evaluation efforts in Washington. This 
report  focuses  on  the  process  of  aggregating  registry 
data, resources used, initial outcomes, lessons learned, 
and  the  utility  of  combining  clinic  data  for  future 
endeavors.
Methods
DPCP  program  staff,  Washington  State  Department 
of Health (DOH) project epidemiologists, and 2 contrac-
tors  worked  together  to  plan,  coordinate  collection  of, 
consolidate,  and  cleanse  CDEMS  data.  The  DPCP  con-
tracted  with  the  CDEMS  technical  support  consultant 
and with Krupski Consulting, Inc, Olympia, Washington, 
a firm that extracts, transforms, and loads data (25). The 
Appendix provides details on the tasks, estimated time, 
and cost for this project.
At the start of this project, epidemiologists spent con-
siderable time working with DPCP staff and the CDEMS 
technical  consultant  to  gain  a  thorough  understanding 
of the development philosophy, implementation, mainte-
nance, and structure of CDEMS and variations between 
clinics to guide clinic recruitment and subsequent data 
consolidation.  CDEMS  is  a  Microsoft  Access  database 
application developed by the Washington State DPCP in 
2002 (24). It is available at no cost to all who wish to use 
it (http://www.cdems.com). The program was designed to 
help medical providers, clinic managers, and other health 
care staff track the care of patients with chronic health 
conditions. CDEMS stores individual patient demograph-
ic information, visit dates, vital signs, medications, diag-
noses, services, laboratory results, and custom notes in 7 
main data tables. Data entry screens, such as the Patient 
Information  Record  and  New  Visit  Form  (Figure),  are 
used to populate the main tables in the database. The 
CDEMS registry has predefined data codes to track dia-
betes care, but these can be modified and measures added 
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is available to download results from several major labo-
ratories  electronically.  Printed  progress  notes,  patient 
lists, and summary reports are generated from the regis-
try database to help deliver services more efficiently and 
effectively and to monitor changes from quality improve-
ment efforts.
CDEMS registries are used predominately in primary 
care  clinics  in  community  and  rural  settings  and  in 
Indian Health Service clinics throughout the state. Most 
clinics  began  using  CDEMS  as  part  of  the  Washington 
State Collaborative (14,26) or National Health Disparities 
Collaborative  (27).  These  collaboratives  use  a  proactive 
approach  that  offers  proven  strategies  to  help  primary 
care practice teams manage care for people with chronic 
diseases. For this reason, we considered most patients in 
CDEMS to be potentially better managed than the general 
diabetes population in Washington state.
Clinics  populated  their  registries  by  either  entering 
data on new patients prospectively, entering data from 
review  of  medical  records  retrospectively,  or  importing 
data  from  other  systems.  Some  clinics  populated  their 
registries with a subset of their patients, whereas others 
used their total diabetes patient population. Demographic 
data were often imported from a billing system and were 
complemented by data abstracted from medical records, 
to capture recent and historical health information going 
back 1 to 2 years. At the time of this project, only 22% of 
clinics used laboratory interfaces to download laboratory 
results electronically.
Because of variations in how clinics used data fields in 
CDEMS, we compiled a master list of data fields associ-
ated with each table in the registry, which included only 
those that would be useful for measuring progress toward 
state and national objectives.
Because CDEMS stores individually identifiable health 
information,  protection  under  the  Health  Insurance 
Portability and Accountability Act (HIPAA) was reviewed 
by  the  HIPAA  officer  for  the  Washington  State  DOH. 
The project was designated as public health surveillance 
and  considered  to  be  in  compliance  with  HIPAA  pri-
vacy rule requirements (28). The Washington State DOH 
Information  Technology  Security  Office  conducted  an 
assessment of data confidentiality and sensitivity before 
clinic recruitment and data aggregation.
To minimize the data transfer burden and encourage 
response, we asked clinics to simply copy their registry 
database, including all patient records, data fields, and 
years  available,  onto  a  CD-ROM,  DVD,  or  floppy  disk 
and send it directly to the DPCP in a return postage-paid 
mailing envelope. We recruited clinics by e-mail initially, 
followed up with a formal letter explaining the project, and 
contacted nonresponding clinics by e-mail and telephone. 
Clinics that participated in the project were later provided 
a summary of results from the combined CDEMS data-
base to compare with their own data.
Collecting, combining, and cleansing data
The  CDEMS  technical  support  contractor  coordinated 
the collection and transfer of databases from the clinics 
to  the  DPCP.  DPCP  staff  logged  clinics’  CDEMS  data-
bases by date of arrival before forwarding data to Krupski 
Consulting for consolidation. This contractor worked close-
ly with project staff and the epidemiologists to identify 
the relevant CDEMS variables and data fields needed to 
assess the number of patients meeting state and national 
objectives. Clinics with multiple locations submitted data 
inconsistently, some providing a database for each location 
and others combining locations into 1 large database. In 
addition, some clinics included only a subset of their total 
patient population. As data were received, project staff cre-
ated a unique code to identify the source of data.
The  aim  of  data  consolidation  was  to  combine  the 
records from source tables in each clinic’s registry into a 
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single master database containing values with consistent 
meaning. Because CDEMS was designed to be adaptable 
to each clinic, clinics entered data in various ways, and 
thus transforming and cleansing the data before aggre-
gation was time-consuming. Values for each field in the 
CDEMS  database  were  standardized  to  reconcile  varia-
tions between clinics. For example, glucose in the original 
datasets received from each clinic may have been recorded 
as  Glu,  GLU,  glu,  glucose,  or  Glucose;  all  terms  were 
changed to glucose in the aggregate database. In addition, 
the contractor ensured that codes predefined in the origi-
nal databases for diagnosis, service, and laboratory fields 
were incorporated into the aggregate database and dealt 
with formatting issues.
To make subsequent data analysis more efficient, the 
contractor worked with project staff and the epidemiolo-
gists to combine and recode similar values. For example, 
all insurance plan names in the database were recoded to 5 
unique values — commercial/private, Medicaid, Medicare, 
self-pay,  or  no  insurance.  Some  field  values  were  auto-
matically assigned, but others had to be done manually, 
case-by-case. Unknown or invalid values were set to null 
in the condensed database. To determine health conditions 
alone, we examined and recoded more than 130 different 
data  field  values.  More  than  200  different  field  values 
were reviewed and recoded for health services, more than 
500  values  for  laboratory  results,  and  more  than  2,000 
values for health care coverage. The contractor added new 
fields to various tables in the combined database to docu-
ment how original values were recoded.
The  contractor  applied  proprietary  software  tools  to 
consolidate data efficiently and cost-effectively. Afterward, 
the  epidemiologists  reviewed  data,  removed  duplicate 
databases, and organized and linked data tables for analy-
sis.  Following  these  activities,  493  records  (<1%)  were 
excluded from further analysis.
Diabetes was recorded in the CDEMS table that stores 
information on a patient’s health conditions by clinic staff 
if a patient had an International Classification of Diseases, 
9th Revision, Clinical Modification (ICD-9-CM) diagnosis 
code of diabetes type 1 or type 2 (confirmed through chart 
audit) and a date of diagnosis. For example, if a patient 
had  diabetes,  a  provider  would  select  a  preset  health 
condition  code  for  diabetes  (Diabetes,  DM-1,  or  DM-2) 
under the health conditions section in the CDEMS New 
Visit Form (Figure). For our analysis, we selected adult 
patients  with  diabetes  who  met  the  following  criteria:   
1) had at least 1 visit, service, or laboratory result in 2004, 
2) were diagnosed with diabetes before 2004 so they had a 
full year to receive services, and 3) were at least 18 years 
old. Patients with gestational diabetes or prediabetes were 
excluded.  The  final  pooled  CDEMS  database  included 
51,233 patients, of which 17,349 met these criteria.
Measures
We  were  able  to  adequately  assess  the  indicators 
described in Table 1, which lists the indicator definitions 
and reporting ranges we selected before analysis. We were 
unable to assess receipt of annual influenza vaccine and 
previous pneumococcal vaccination because patients are 
usually referred to other facilities for vaccinations, and few 
clinics have a feedback system to monitor outside services. 
Further, most clinics did not collect historical information 
on lifetime pneumococcal vaccination.
Statistical analysis
The  data  were  analyzed  using  Microsoft  Access  2003 
(Microsoft Corp, Redmond, Washington) and Stata statis-
tical software, version 9.0 (StataCorp LP, College Station, 
Texas).  Percentages  and  95%  confidence  intervals  were 
calculated using the binomial Wald method. Median per-
centages  and  ranges  across  clinics  were  also  calculated 
because of substantial variation in rates of meeting diabe-
tes care objectives among clinics.
Results
Most of the 132 eligible Washington clinics (85%) sub-
mitted data for this project. More than two-thirds (68%) 
provided data that were included in final sample of 17,349 
adult patients with diabetes from 90 primary care office 
settings. Clinics in the combined database ranged in size 
from 1 to 2,483 patients with diabetes in 2004. More than 
90%  of  clinics  participated  in  a  collaborative  or  were  a 
satellite clinic of an organization that participated in a 
collaborative. Approximately 40% were community health 
centers or federally qualified community health centers.
We excluded data from 22 clinics (17%) from our analy-
sis  because  the  clinic  database  could  not  be  opened  or 
combined, the clinic’s registry was not implemented at the 
start of the project period, or the clinic’s data collection and 
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patients. No particular pattern was noted with the infor-
mation available from these clinics compared with that 
from clinics included in the combined database.
Twenty clinics (15%) did not participate in the project 
because they did not start their registry until late in 2004, 
had staff turnover involving the CDEMS coordinator at 
the clinic, or lacked time. We had insufficient information 
to compare patient populations between CDEMS clinics 
that submitted data and CDEMS clinics that did not. The 
clinics that did not participate came mostly from nonur-
ban areas, but we observed no further differences such as 
private vs public status, participation in the Washington 
State Collaborative, or geographic location.
The average age of patients with diabetes in the com-
bined database was 59 years (range 18-100 years). Slightly 
more  than  half  (53%)  were  female.  Race/ethnicity  was 
documented for only 60% of patients, 59% of whom were 
listed as white, 21% Hispanic, 8% African American, 6% 
Asian,  3%  American  Indian/Alaska  Native,  2%  Native 
Hawaiian/Other Pacific Islander, and less than 1% other 
race.  Approximately  38%  of  the  participants  were  com-
mercially insured, 22% had Medicare, 19% had unknown 
insurance  status,  8%  had  no  health  insurance,  9%  had 
Medicaid, 5% were self-pay, and less than 1% had other 
sponsored care.
The age and sex distribution of adult patients with dia-
betes in the CDEMS database was different from that of 
the overall Washington adult diabetes population (Table 
2). A larger proportion of CDEMS patients with diabetes 
were aged 65-74 years and a smaller proportion were aged 
75 years or older compared with the overall population, 
and the proportion of women was greater among CDEMS 
patients.  Hispanics  and  Asians  appeared  to  be  overrep-
resented in CDEMS compared with the state. However, 
because the race and ethnic origin of many patients was 
not recorded in CDEMS, we are unable to draw conclusions 
about the differences between these populations. Similarly, 
the large proportion of CDEMS patients listed as having 
“unknown  insurance  status”  means  that  we  are  unable 
to comment on differences in health insurance coverage 
between CDEMS and the overall statewide populations.
Tables  3  and  4  show  the  distribution  of  processes  of 
diabetes  care  and  intermediate  health  outcomes  among 
adult patients with diabetes in the aggregate database. 
More  than  50%  of  patients  were  above  recommended 
target levels for HbA1c testing, foot examination, HbA1c 
control, and LDL cholesterol control. Fewer patients met 
recommendations for nephropathy assessment, eye exami-
nations, and blood pressure control. Performance on these 
indicators varied across clinics. Table 5 further describes 
the values for each of the intermediate health outcomes 
assessed.
Table 6 compares results from the consolidated CDEMS 
database with results from other state and national data 
sources. CDEMS patients had more favorable results for 
HbA1c  and  LDL  cholesterol  levels  than  did  the  overall 
population,  and  their  results  did  not  differ  noticeably 
for  receiving  an  HbA1c  test,  LDL  cholesterol  test,  or 
nephropathy screen in the past year. CDEMS results were 
less favorable for annual foot examinations, annual eye 
examinations, and biannual HbA1c, compared with other 
data sources.
Discussion
We sought to determine the feasibility of using aggregate 
clinic data for ongoing diabetes surveillance and evaluation 
efforts in Washington State. Our work shows that with 
committed  staff  time,  provider  support,  and  resources, 
data from clinical information systems like CDEMS can be 
combined to address a deficiency in state surveillance and 
evaluation systems — specifically, the inability to capture 
clinical values to measure intermediate health outcomes for 
diabetes. The intent is to use the CDEMS measures that do 
not appear in BRFSS to complement BRFSS data, with 
the understanding that one of the limits of the aggregate 
CDEMS database is that it reflects only 9% of the diabetes 
population  —  and  they  are  probably  specially  managed 
because most clinics have received intensive training on 
implementing the Chronic Care Model (29,30).
CDEMS  patients’  better  HbA1c  and  LDL  cholesterol 
levels compared with the overall state population of people 
with diabetes (Table 6) may be because most CDEMS clin-
ics  were  alumni  of  the  Washington  State  Collaborative 
(14,26) or Health Disparities Collaborative (27) or were 
affiliated with a clinic that participated in a collaborative 
that focused on these measures.
CDEMS screening results for HbA1c, LDL cholesterol, or 
nephropathy in the past year were not noticeably different 
VOLUME 5: NO. 4
OCTOBER 2008
  www.cdc.gov/pcd/issues/2008/oct/07_0156.htm • Centers for Disease Control and Prevention  5
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.VOLUME 5: NO. 4
OCTOBER 2008
compared with data sources that were not restricted to spe-
cially managed populations. CDEMS results also were not 
as good for annual foot examinations, annual eye examina-
tions, and biannual HbA1c tests.
Some differences between the CDEMS results and those 
of other data sources could be attributable to differences in 
how measures are defined, how ranges for responses are 
defined, how data are collected (clinical data vs self-report), 
and how data are entered into systems, or they may rep-
resent a true difference in outcomes. For example, the low 
prevalence of receiving eye examinations in CDEMS com-
pared with self-reported eye examination data from state-
wide BRFSS is not unexpected. Follow-up documentation 
on patients referred for eye examinations outside the care 
clinic is rare, and poor agreement between self-report and 
medical record data on annual eye examinations has been 
documented elsewhere (31). Without a detailed study com-
paring the data sources, clinics, patients who are captured 
within the data sources, or study methods, it is difficult to 
explain observed differences.
Lessons learned from combining data
A  project  of  this  magnitude  required  a  commitment 
from the state DPCP to ensure that financial and staff 
resources were available to complete the work. The project 
required substantial time, coordination, and communica-
tion from internal and external staff who assisted with 
project  management  and  clinic  recruitment;  contractors 
and  programmers,  who  managed  data  submission  and 
consolidation; CDEMS staff, who provided technical sup-
port; and epidemiologists, who provided project coordina-
tion, project design, data consultation, and analysis.
Clinic recruitment was facilitated by established rela-
tionships between DPCP and CDEMS users through the 
ongoing technical assistance provided to clinics by DPCP 
as part of the Washington State Collaborative. We learned 
to  work  with  the  clinics’  central  registry  coordinators 
(especially  for  multisite  implementations)  rather  than 
each clinic within a larger system. It was also necessary to 
be explicit about which project we represented, since mul-
tiple  quality  improvement  evaluation  projects  occurred 
simultaneously within the Washington State DOH.
We  found  we  needed  to  provide  several  options  for 
ensuring  patient  privacy  and  data  security  with  the   
clinics and Washington State DOH information technology 
staff before arriving at a simple and acceptable process for 
gathering data. Although we initially favored a secure file 
transfer protocol Web site as a central repository for data 
submission, this option would have caused undue burden, 
compromising  clinic  participation.  Even  with  the  easier 
option of copying the databases to a CD, several clinics 
needed our assistance to transfer their data.
During data consolidation, we needed to complete sev-
eral tasks to analyze data more efficiently (eg, reviewing 
various  field  codes  from  each  clinic,  combining  similar 
values, handling different types of data, and identifying 
data fields to define measures). After data were combined, 
more  time  was  spent  identifying  unique  patients  and 
removing duplicate data. Resolving duplications first may 
have minimized postconsolidation cleanup of the data and 
ensured accuracy of numerator and denominator counts 
required  to  estimate  the  percentage  receiving  care.  It 
would have been useful to have a comprehensive codebook 
before analysis to identify field names and values, track 
programming  used  to  combine  data,  and  note  changes 
made to the original data submitted.
After data were combined and reviewed, we still needed 
to modify some project measures. For example, because 
there is no standard method for reporting nephropathy 
results in CDEMS, we reviewed results manually to deter-
mine which met the definition for annual screening. The 
distinctive ability for the user to customize CDEMS led to 
variation in the data that required additional effort on our 
part to standardize before analysis.
Limitations
Our  project  had  several  limitations.  First,  it  may  be 
biased toward better outcomes because participating clin-
ics are engaged in quality improvement efforts, although 
quality improvement efforts may have focused on a few 
measures  only,  and  specialty  clinics  are  generally  not 
represented in CDEMS. Second, in this initial look at the 
data, only unweighted aggregate population statistics are 
reported; thus, clinics with larger patient populations may 
disproportionately affect the results. Our combined data 
represent  a  convenience  sample,  and  detailed  informa-
tion to construct sample weights was not available. In the 
future, additional time and resources will be required to 
collect detailed information on each clinic and account for 
differences between clinics. Third, individual clinic datas-
ets reflect variations in entry protocols, reporting methods, 
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registry data for a few objectives during the project period. 
Our overall rates may have been higher had we been able 
to account for inconsistencies in data collection intensity 
and  measurement  standards  across  clinics.  Because  we 
were unable to identify new patients based on the start 
date field in CDEMS (ie, clinics used different definitions 
for “start date”), our results may include patients who did 
not participate throughout the entire project period. These 
limitations highlight the need for improved standards in 
CDEMS data collection and reporting.
Implications
This  project  reflects  the  status  of  state  and  national 
objectives for approximately 9% of adults with diabetes 
in Washington in 2004. However, the number of patients 
tracked in CDEMS grew by 83% from 2004 to 2007 (32). 
Furthermore, provider use of CDEMS grew by 39% during 
the same period (32). As more providers use clinical infor-
mation systems like CDEMS, the potential to gather more 
representative data will improve. This data quality will be 
necessary as provider accountability, pay-for-performance, 
and public reporting of quality measures are increasingly 
emphasized. How the growing use of electronic medical 
records (EMRs) will influence CDEMS use has yet to be 
determined,  but  some  clinics  in  Washington  use  both 
CDEMS and EMR registries (17% in 2007) because of the 
limited usefulness of EMR systems to track patients with 
chronic conditions (32,33).
This project shows there is a need to improve standard-
ization of CDEMS data entry and reporting for a mini-
mum number of key measures to track progress over time, 
to  provide  appropriate  and  valid  comparison  data,  and 
to help organizations to share knowledge about progress 
with one another. For example, establishing a consistent 
feedback  loop  and  data  controls  to  capture  completed 
referrals for eye examinations would improve monitoring 
of this objective in the population.
Conclusion
This project shows how one state combined individual 
clinic data from chronic disease registries as part of an 
overall effort to enhance its diabetes surveillance capacity. 
Being able to monitor the status of diabetes care, track 
changes, and conduct peer comparisons through the collec-
tion, combination, and use of clinic data may help stimu-
late health practitioners to implement broad systematic 
improvements and provide data to the DPCP for future 
program plans.
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Tables
Table 1. Indicator Definitions and Reporting Ranges Used to Analyze Consolidated Registry Data From the Washington State 
Chronic Disease Electronic Management System (CDEMS), 2004
Indicator (Definitiona) Valid Reporting Range(s)
Additional Edit Filters and Exclusion 
Criteria Source
Annual foot examination 
(have at least 1 ICD--CM 
code for foot exam in 2004)
Not applicable Only included patients with code indicat-
ing exam was completed. Examination 
with referral or declined status was 
excluded.
Used recommendations from the 
DPCP and CDEMS technical sup-
port staff.
Annual eye examination (have 
at least 1 ICD--CM code for 
eye exam in 2004)
Not applicable Only included patients with code indicat-
ing exam was completed. Examination 
with referral or declined status was 
excluded.
Used recommendations from 
DPCP and CDEMS technical sup-
port staff.
Abbreviations: ICD--CM, International Classification of Diseases, 9th Revision, Clinical Modification; DPCP, Diabetes Prevention and Control Program; LDL, 
low-density lipoprotein; HDL, high-density lipoprotein; DOH, Department of Health; NHANES, National Health and Nutrition Examination Survey; HbA1c, 
hemoglobin A1c. 
a All services and results had to have a corresponding date that was between January 1, 2004, and December 1, 2004. 
b Calculated by dividing urinary albumin range by urinary creatinine range; urinary albumin multiplied by 1,000 to calculate micrograms. 
c Included results listed as less than or greater than, positive, negative, within limit, zero (we assumed this meant result was negative), ratios that were listed 
in valid reporting ranges, and 1+ or + for 24-hour urine protein. 
d Calculated by subtracting HDL from total cholesterol.
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Indicator (Definitiona) Valid Reporting Range(s)
Additional Edit Filters and Exclusion 
Criteria Source
Annual nephropathy screen-
ing (have at least 1 lab result 
for any of the following tests 
in 2004: urinary albumin/
microalbumin, serum albu-
min/microalbumin, 24-hour 
urine protein, or microalbu-
min-to-creatinine ratio)
Urinary albumin/microalbumin: 0.1-600 
mg 
Serum albumin/microalbumin: 1-6 g/dL
Urinary creatinine: 1-0,000 mg/dL
Serum creatinine: 0.1-20 mg/dL
Albumin/creatinine ratio: 0.0-600,000 
µg/mg or 0.0000-600 µg/mgb 
24-hour urine protein: -2,000 mg/dL
Excluded patients with nephropathy diag-
nosis before 2004 or before nephropa-
thy test in 2004. 
Because there is no standard way of 
reporting nephropathy results in CDEMS 
registries, nonnumeric results were 
subject to manual review by project epi-
demiologists.c 
Contacted Quest Diagnostics 
national reference lab for valid 
reporting ranges.
Annual LDL cholesterol test 
and control (have at least 1 
lab result for LDL or non-HDL 
cholesterol in 2004)
LDL cholesterol: 10-50 mg/dL 
HDL cholesterol: 5-20 mg/dL
Total cholesterol: 40-1,000 mg/dL
Non-HDL cholesterol: 5-710 mg/dLd 
Not applicable Contacted Quest Diagnostics 
national reference lab for valid 
reporting ranges (confirmed ranges 
with Washington State DOH and 
public health laboratories).
Annual blood pressure screen 
and control (have at least 1 
measurement result for blood 
pressure in 2004)
Systolic: 60-00 mm Hg (lower limit 
recommended by Washington State 
DOH consultants) 
Diastolic: 0-280 mm Hg (upper limit 
calculated from limit on difference 
between systolic and diastolic blood 
pressure values)
Systolic blood pressure had to be greater 
than diastolic blood pressure. 
Both systolic and diastolic values were 
not null.
Difference between systolic and diastolic 
blood pressure could not be <20 mm 
Hg or >100 mm Hg.
Type of visit coded as office visit.
Used information in NHANES 
200-2004 physicians’ examina-
tion procedures manuals and rec-
ommendations from Washington 
State DOH consultants for valid 
reporting ranges. 
Used additional edits recom-
mended by NHANES, DPCP, and 
CDEMS technical support staff 
when applicable to this data 
source.
Annual/biannual HbA1c test-
ing and control (have at least 
1 lab result for HbA1c test in 
2004)
2% to 20% A1c tests had to be at least 1 days 
apart to be considered separate tests.
Used information in NHANES 
200-2004 laboratory proce-
dures manuals for valid reporting 
ranges. Referred to Bureau of 
Primary Care Health Disparities 
Collaborative guidelines for deter-
mining frequency of tests.
 
Abbreviations: ICD--CM, International Classification of Diseases, 9th Revision, Clinical Modification; DPCP, Diabetes Prevention and Control Program; LDL, 
low-density lipoprotein; HDL, high-density lipoprotein; DOH, Department of Health; NHANES, National Health and Nutrition Examination Survey; HbA1c, 
hemoglobin A1c. 
a All services and results had to have a corresponding date that was between January 1, 2004, and December 1, 2004. 
b Calculated by dividing urinary albumin range by urinary creatinine range; urinary albumin multiplied by 1,000 to calculate micrograms. 
c Included results listed as less than or greater than, positive, negative, within limit, zero (we assumed this meant result was negative), ratios that were listed 
in valid reporting ranges, and 1+ or + for 24-hour urine protein. 
d Calculated by subtracting HDL from total cholesterol.
Table 1. (continued) Indicator Definitions and Reporting Ranges Used to Analyze Consolidated Registry Data From the 
Washington State Chronic Disease Electronic Management System (CDEMS), 2004Table 2. Comparison of Demographic Characteristics Between Adult Patients With Diabetes in the Consolidated Chronic 
Disease Electronic Management System (CDEMS) and Adults in the General Washington State Diabetes Population, 2004
Demographics
CDEMS Diabetes Populationa Washington State Diabetes Populationb
Patients, No. % (95% CI) BRFSS Respondents, No. % (95% CI)c
Age, y
18-24 128 0.7 (0.6-0.) 0 1.5 (0.-2.4)
25-4 604 .5 (.2-.8) 141 4.6 (.8-5.6)
5-44 1,820 10.5 (10.0-10.) 404 10.8 (.5-12.1)
45-54 ,746 21.6 (21.0-22.2) 855 20.8 (1.-22.5)
55-64 4,70 27. (26.6-27.) 1,46 26.0 (24.4-27.6)
65-74 ,614 20.8 (20.2-21.4) 1,11 18.0 (16.7-1.)
≥75 2,702 15.6 (15.0-16.1) 65 18. (17.0-1.7)
Sex
Male 8,048 46. (46.1-47.6) 1,66 50. (48.4-52.2)
Female ,117 5.1 (52.4-5.) 2,0 4.7 (47.8-51.6)
Race/ethnicity
White 6,281 6.2 (5.5-6.) 4,21 8.5 (81.-85.0)
African American 80 4.8 (4.5-5.1) 120 .5 (2.8-4.5)
Asian 668 . (.6-4.1) 76 2. (1.7-.0)
Native Hawaiian or Other Pacific Islander 21 1. (1.2-1.5) 0 1.1 (0.6-1.7)
American Indian or Alaska Native 27 1.6 (1.4-1.8) 112 2.5 (1.-.2)
Hispanic 2,276 1.1 (12.6-1.6) 25 5. (4.5-6.)
Other race 2 0.2 (0.1-0.2) 14 0.4 (0.2-0.7)
Unknown 6,761 .0 (8.2-.7) 57 1.4 (1.0-2.0)
Health care coverage
Yes 11,88 68.5 (67.8-6.2) 4,50 1.1 (8.-2.2)
No 2,118 12.2 (11.7-12.7) 60 8.8 (7.7-10.0)
Unknown ,48 1. (18.7-1.) <10d —
 
Abbreviations: CI, confidence interval; BRFSS, Behavioral Risk Factor Surveillance System. 
a CDEMS, 2004, Washington State Department of Health. Missing or out-of-range values were excluded. 
b Washington State BRFSS, 200-2005, Washington State Department of Health. Unknown, refused, and missing responses were excluded. 
c Calculated using the binomial Wald method. 
d Number of responses was not sufficient to calculate reliable estimates. 
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Table 3. Distribution of Diabetes Care Among Adult Patients With Diabetes in Chronic Disease Electronic Management 
System (CDEMS) Registries, Washington State, 2004
Diabetes Care Process
Overall Across Clinics
n/N % (95% CI)a Median, % Range, %
At least 1 HbA1c test in past year 15578/174 8.8 (8.-0.2) 0.4 61.5-100.0
At least 2 HbA1c tests in past year 52/174 5. (5.2-54.6) 4.6 28.-86.1
Foot examination in past year 165/174 52.8 (52.1-5.6) 54.5 6.0-84.4
Eye examination in past year 614/174 5.4 (4.7-6.1) 28.4 .0-5.1
Nephropathy screening in past yearb 7184/15628 46.0 (45.2-46.8) 42.7 .1-8.
LDL test in past yearc 1284/174 74.0 (7.4-74.7) 76. 51.6-8.1
Blood pressure screening in past year 14787/174 85.2 (84.7-85.8) . 44.2-.0
 
Abbreviations: CI, confidence interval; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein cholesterol. 
a Calculated using the binomial Wald method. 
b Missing or out-of-range values were excluded, resulting in a different denominator.  
c Includes patients with non-high density lipoprotein (HDL) cholesterol test (calculated by subtracting HDL from total cholesterol) in past year. 
Table 4. Distribution of Intermediate Health Outcomes Among Adult Patients With Diabetes in Chronic Disease Electronic 
Management System (CDEMS) Registries, Washington State, 2004 
Intermediate Health Outcome
Overall Across Clinics
n/Na % (95% CI)b Median, % Range, %
Last HbA1c test <7.0% 8,045/15,578 51.6 (50.-52.4) 52.0 .-7.2
Last HbA1c test <8.0% 11,606/15,578 74.5 (7.8-75.2) 75. 57.7-1.7
Last blood pressure reading <10/80 mm Hg 5,00/14,787 4.0 (.-4.8) 2.5 1.1-5.2
Last blood pressure reading <140/0 mm Hg ,58/14,787 67. (66.6-68.1) 64.8 2.4-7.4
Last LDL cholesterol test <100 mg/dLc 7,25/12,84 56.5 (55.6-57.) 55.7 .-74.5
Last LDL cholesterol test <10 mg/dLd 10,50/12,84 81.8 (81.2-82.5) 81.4 66.7-1.6
 
Abbreviations: CI, confidence interval; LDL, low-density lipoprotein; HbA1c, hemoglobin A1c. 
a Different denominators in this column reflect missing or out-of-range values that were not used in calculations. 
b Calculated using the binomial Wald method. 
c Includes patients with last non-high density lipoprotein (HDL) cholesterol test (calculated by subtracting HDL from total cholesterol) <10 mg/dL. 
d Includes patients with last non-HDL cholesterol test <160 mg/dL. 
Table 5. Values for Intermediate Health Outcomes Among Adult Patients With Diabetes in Chronic Disease Electronic 
Management System (CDEMS) Registries, Washington State, 2004 
Intermediate Health Outcome Median Mean (SD) Range
Last HbA1c test (%) 6. 7. (1.7) 2-1
Last systolic blood pressure reading (mm Hg) 10.0 10.0 (16.7) 70-210
Last diastolic blood pressure reading (mm Hg) 78.0 76.5 (10.7) 6-140
Last LDL test (mg/dL) 8.0 101.8 (.5) 10-27
Last non-HDL test (mg/dL)a 12.0 18.2 (42.1) 8-68
 
Abbreviations: SD, standard deviation; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol. 
a “Non-HDL” is calculated by subtracting HDL from total cholesterol. VOLUME 5: NO. 4
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Table 6. Comparison of Diabetes Outcomes From the Consolidated Chronic Disease Electronic Management System 
(CDEMS)a With Outcomes From Other Data Sources  
  CDEMS, % Comparison Data, % Source
Diabetes Care Process
Foot examination in past year 52.8 74.1 WA BRFSSb
Eye examination in past year 5.4 70.2 WA BRFSS
48.8 Commercial HEDISc
44.1 Medicaid HEDISc
64.2 Medicare HEDISc
58.0 NHISd
At least 1 HbA1c test in past year 8.8 1.8 WA BRFSS
84.6 Commercial HEDIS
7. Medicaid HEDIS
87. Medicare HEDIS
At least 2 HbA1c tests in past year 5. 75.2 WA BRFSS
LDL cholesterol test in past yeare 74.0 88.4 Commercial HEDIS
74.8 Medicaid HEDIS
0.6 Medicare HEDIS
Nephropathy screening in past year 46.0 48. Commercial HEDIS
4.1 Medicaid HEDIS
52.6 Medicare HEDIS
Intermediate Health Outcome
Last HbA1c test <7.0% 51.6 7.0 NHANESe
Last HbA1c test <8.0% 74.5 Data unavailable  
Last HbA1c test >.0% 1.2 1. Commercial HEDIS
4.5 Medicaid HEDIS
24. Medicare HEDIS
Last blood pressure reading <10/80 mm Hg 4.0 5.8 NHANES
Last blood pressure reading <140/0 mm Hg 67. Data unavailable  
Last LDL test <100 mg/dLf 56.5 4.8 Commercial HEDIS
27. Medicaid HEDIS
41.2 Medicare HEDIS
Last LDL test <10 mg/dLg 81.8 60.5 Commercial HEDIS
47.0 Medicaid HEDIS
66. Medicare HEDIS
 
Abbreviations: LDL, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1c. 
a Washington State Department of Health, 2004. 
b Washington State Behavioral Risk Factor Surveillance System, 200-2005, Washington State Department of Health. 
c Healthcare Effectiveness Data and Information Set 2004, National Committee for Quality Assurance. 
d National Health Interview Survey (NHIS), 200, National Center for Health Statistics. 
e National Health and Nutrition Examination Survey, 1-2000, National Center for Health Statistics. 
f Includes patients with non-high density lipoprotein cholesterol (HDL) test (calculated by subtracting HDL from total cholesterol) in past year. 
g Includes patients with last non-HDL cholesterol test <160 mg/dL.VOLUME 5: NO. 4
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Epidemiology staff
Estimated time (hours): 1680 
Estimated cost: $46,800
Tasks: 
1.  Designed and documented project.
2.  Reviewed possible data sources.
.  Learned registry program and technical functions.
4.  Defined objectives to be measured for the purposes of database manip-
ulation.
5.  Coordinated compliance with Health Insurance Portability and 
Accountability Act regulations.
6.  Coordinated information technology needs and confidentiality of 
patients.
7.  Coordinated human subjects and institutional review board consider-
ations.
8.  Organized logistics of CDEMS clinic recruitment.
.  Reviewed inclusion and exclusion criteria for identification of study  
population.
10. Coordinated CDEMS Technical Support and Consolidation Technical 
Support contractors.
11. Conducted preliminary CDEMS analysis and programming before receipt 
of final aggregated dataset.
12. Worked with contractors to determine acceptable value ranges for data 
analysis.
1. Set up final aggregate CDEMS dataset.
14. Cleansed and sorted dataset after contractors submitted the final data-
set.
15. Analyzed and documented data.
16. Prepared and disseminated results.
Diabetes Prevention and Control Program staff
Estimated time (hours): 60 
Estimated cost: $8,400
Tasks: 
1.  Defined objectives to be measured for the purposes of database manip-
ulation.
2.  Wrote statement of work for contractors.
.  Analyzed and administered budget.
4.  Organized logistics of CDEMS clinic recruitment.
5.  Coordinated letters sent to CDEMS clinics.
6.  Received and transferred databases.
7.  Cleansed data and determined acceptable value ranges for data analy-
sis.
8.  Coordinated resources and personnel involved in dissemination of 
results.
.  Prepared and disseminated results.
CDEMS technical support and consultant contractors
Estimated time (hours): not applicable — reimbursed for products 
Estimated cost: $7,000
Tasks: 
1.  Identified key indicators that must be captured and available for analy-
sis.
2.  Created a standard set of instructions for clinics that describes how to 
assemble and transfer the CDEMS database.
.  Assisted clinics with the CDEMS database transfer.
4.  Maintained confidentiality of patients during data transfer, cleansing, 
and aggregation.
5.  Sent out e-mail reminders to clinics to request data if there was no 
response to the first recruitment letter.
6.  Received CDEMS databases and created identification of the source 
clinic.
7.  Worked with the technical support contractor to convert any Diabetes 
Electronic Management System (DEMS) databases (an earlier version 
of CDEMS ) to the current version of CDEMS.
8.  Created a standard set of instructions for data transfer of CDEMS clinic 
data.
.  Created a list of clinics that sent their database.
10. Documented changes made to original datasets.
11. Submitted original individual clinic databases for analysis by epidemiolo-
gists.
12. Submitted final cleansed aggregated CDEMS dataset for analysis by 
epidemiologists.
Appendix. Project Costs, Time, and Tasks for Consolidating Chronic Disease Electronic 
Management System (CDEMS) Registry Data to Describe Diabetes Care in Washington 
State